Peter Diamandis Executive Advisory Board Member At Immunis

Peter Diamandis, M.D. received degrees in molecular genetics and aerospace engineering from MIT and is a Harvard-trained physician. His entrepreneurship has led to the creation of over 25 companies in the areas of space, education, venture capital and longevity. Named by Fortune as one of the “World’s 50 Greatest Leaders,” Dr. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which funds the design and operation of large-scale incentive competitions. As the executive founder of Singularity University, Dr.

Diamandis counsels the world’s leaders on exponentially growing technologies with programs such as Abundance360 and the Abundance Platinum Longevity Program. He is the co-Founder and Vice-Chairman of the cellular therapeutics company, Celularity, Inc., and of Vaxxinity, Inc., which develops vaccines against COVID and chronic disease. Dr. Diamandis is also the co-Founder & Executive Chairman of Fountain Life, a co-Founder of BOLD Capital Partners and a Board Member of four successful SPAC exits. Dr. Diamandis’ books, blogs, podcasts and webinars educate millions of individuals regularly.

Peter Diamandis, M.D. received degrees in molecular genetics and aerospace engineering from MIT and is a Harvard-trained physician. His entrepreneurship has led to the creation of over 25 companies in the areas of space, education, venture capital and longevity. Named by Fortune as one of the “World’s 50 Greatest Leaders,” Dr. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which funds the design and operation of large-scale incentive competitions. As the executive founder of Singularity University, Dr.

Diamandis counsels the world’s leaders on exponentially growing technologies with programs such as Abundance360 and the Abundance Platinum Longevity Program. He is the co-Founder and Vice-Chairman of the cellular therapeutics company, Celularity, Inc., and of Vaxxinity, Inc., which develops vaccines against COVID and chronic disease. Dr. Diamandis is also the co-Founder & Executive Chairman of Fountain Life, a co-Founder of BOLD Capital Partners and a Board Member of four successful SPAC exits. Dr. Diamandis’ books, blogs, podcasts and webinars educate millions of individuals regularly.

IRVINE, Calif. , Sept. 20, 2022 /PRNewswire/ -- Immunis Inc., a private biotechnology company developing an immunomodulatory secretome for age and disease-related immune decline in Phase 1/2a testing, welcomes Peter H. Diamandis, M.D. to the Executive Advisory Board. Dr.

Diamandis received degrees in molecular genetics and aerospace engineering from MIT and is a Harvard-trained physician. His entrepreneurship has led to the creation of over 25 companies in the areas of space, education, venture capital and longevity. Named by Fortune as one of the "World's 50 Greatest Leaders," Dr. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which funds the design and operation of large-scale incentive competitions. As the executive founder of Singularity University, Dr. Diamandis counsels the world's leaders on exponentially growing technologies with programs such as Abundance360 and the Abundance Platinum Longevity Program.

He is the co-Founder and Vice-Chairman of the cellular therapeutics company, Celularity, Inc., and of Vaxxinity, Inc., which develops vaccines against COVID and chronic disease. Dr. Diamandis is also the co-Founder & Executive Chairman of Fountain Life, a co-Founder of BOLD Capital Partners and a Board Member of four successful SPAC exits. Dr. Diamandis' books, blogs, podcasts and webinars educate millions of individuals regularly. Immunis is honored to have such an innovative expert join the team.

"I haven't been this excited about a biotech company in a long time! The approach Immunis is taking to reproduce the stem cell secretome and the focus on Sarcopenia is brilliant. Besides the multitude of potential longevity related benefits, battling Sarcopenia could have one of the biggest impacts on healthy aging we've seen this decade," says Dr. Peter H. Diamandis. "I haven't been this excited about a biotech company in a long time!" - Dr.

Peter H. Diamandis. About Immunis Inc.Immunis is a private biotechnology company developing a novel immunomodulatory secretome product for the various manifestations of age and disease-related immune decline. The STEM product line leverages Immunis' leading-edge capabilities in stem cell technology to deliver all natural, all human immune modulators in their natural, relative physiological concentrations. ExecAtlas delivers real-time insight into who-knows-who, paving the way for warm introductions that create opportunities. Executive Founder at Singularity University

As an entrepreneur, Diamandis has started over 25 companies in the areas of health-tech, space, venture capital and education. He is Co-founder and Vice-Chairman of two public companies, Celularity and Vaxxinity. Dr. Diamandis is Co-founder & Chairman of Fountain Life, a fully-integrated platform delivering predictive, preventative, personalized and data-driven health. Finally, he also serves as Co-founder of BOLD Capital Partners, a venture fund with a half-billion dollars under management being invested in exponential technologies and longevity companies. Diamandis is a New York Times Bestselling author of four books: Abundance – The Future Is Better Than You Think, BOLD – How to go Big, Create Wealth & Impact the World and The...

Most recently he co-Authored the #1 best seller LIFE FORCE with Tony Robbins which chronicles the extraordinary healthcare and biotech revolution unfolding before our eyes. He earned degrees in molecular genetics and aerospace engineering from MIT and holds an M.D. from Harvard Medical School. Diamandis’ favorite saying is “The best way to predict the future is to create it yourself.” Source: X PRIZE FOUNDATION on 10/28/2025 Executive Founder at Singularity University

IRVINE, Calif. , Sept. 20, 2022 /PRNewswire/ — Immunis Inc., a private biotechnology company developing an immunomodulatory secretome for age and disease-related immune decline in Phase 1/2a testing, welcomes Peter H. Diamandis, M.D. to the Executive Advisory Board. Dr.

Diamandis… Peter H. Diamandis (/ˌdiːəˈmændɪs/ DEE-ə-MAN-diss; born May 20, 1961) is an American engineer, physician,[1] and entrepreneur. He is best known as the founder and chairman of the XPRIZE Foundation, and the cofounder and executive chairman of Singularity University. He is also cofounder and former CEO of the Zero Gravity Corporation, cofounder and vice chairman of Space Adventures Ltd., founder and chairman of the Rocket Racing League, cofounder of the International Space University,... Diamandis was born in the Bronx, New York, to Greek immigrants.[3] At age 12, Diamandis won first place a rocket design competition.[4]

After graduating from Great Neck North High School in 1979, Diamandis attended Hamilton College for his first year, then transferred to the Massachusetts Institute of Technology to study biology and physics. During his second year at MIT in 1980, he cofounded Students for the Exploration and Development of Space.[5] Diamandis graduated from MIT in 1983[6][7] and entered Harvard Medical School to pursue his MD through the Harvard–MIT Program in Health Sciences and Technology. During his second year of medical school, he cofounded the Space Generation Foundation to promote projects and programs that would help the "Space Generation"—all those born since the flight of Sputnik—get off the planet.[4] In 1986, Diamandis put his medical degree on hold and returned to MIT to pursue a master's degree in aeronautics and astronautics, conducting research at NASA Johnson Space Center, the MIT Man Vehicle Laboratory... at MIT, Diamandis returned to Harvard to complete his M.D.[9]

People Also Search

• Peter Diamandis - Executive Advisory Board Member at Immunis
• Peter Diamandis - Executive Advisory Board Member at Immunis, Inc ...
• Immunis Welcomes Dr. Peter Diamandis to the Executive Advisory Board
• Immunis Lands Diamandis for Advisory Board - ocbj.com
• Dr. Peter Diamandis Joins Executive Advisory Board for Immunis
• Therapeutics for Age-Related Diseases and Immune Dysfunction
• Peter H. Diamandis MD - Executive Bio, Work History, and Contacts ...
• Immunis Welcomes Dr. Peter Diamandis to the Executive Advisory Board ...
• Peter Diamandis - Wikipedia
• Latest News about Immunis' Investigational Secretome Treatment ...